p38 Mitogen-activated protein kinase and c-Jun-NH2-terminal kinase regulate interleukin-8 and RANTES production in hyperosmolarity stimulated human bronchial epithelial cells

p38 Mitogen-activated protein kinase and c-Jun-NH2-terminal kinase regulate interleukin-8 and RANTES production in hyperosmolarity stimulated human bronchial epithelial cells
复制标题

DOI:
10.1046/j.1440-1843.2002.00401.x
复制
发表时间:
2002-09-01
期刊:
影响因子:
6.9
通讯作者:
Horie, T
Horie, T
中科院分区:
医学2区
文献类型:
--
作者:
Furuichi, S;Hashimoto, S;Horie, T

文献摘要

被引文献

相似文献

目的:我们以前已经表明,p38丝裂原活化蛋白激酶(MAPK)调节,至少部分,高渗诱导的白细胞介素(IL)-8在人支气管上皮细胞(BEC)的表达。在先前的研究中,高渗也激活c-Jun-NH 2-末端激酶(JNK);然而,JNK信号通路的作用尚未确定。在本研究中,我们使用JNK信号通路的新型抑制剂CEP 11004来研究JNK信号通路在高渗诱导的BEC产生IL-8和RANTES中的作用,以澄清这些问题。已与SB 203580预孵育的支气管上皮细胞,将CEP 11004或其组合暴露于高渗培养基中,然后测定这些细胞中p38 MAPK和JNK磷酸化活性以及培养上清液中IL-8和RANTES浓度。高渗可诱导p38 MAPK和JNK的苏氨酸和酪氨酸磷酸化,SB 203580和CEP 11004分别抑制p38 MAPK和JNK的活性,SB 203580和CEP 11004部分抑制IL-8和RANTES的产生,PD 98059则无此作用;结论:p38 MAPK和JNK信号通路参与了高渗诱导BEC产生IL-8和RANTES的调节。
Objective: We have previously shown that p38 mitogen-activated protein kinase (MAPK) regulates, at least in part, hyperosmolarity induced interleukin (IL)-8 expression in human bronchial epithelial cells (BEC). In the previous study, hyperosmolarity also activated c-Jun-NH2-terminal kinase (JNK); however, the role of the JNK signalling pathway has not been determined. In the present study, we examined the role of the JNK signalling pathway in hyperosmolarity induced IL-8 and RANTES production by BEC using the novel inhibitor of the JNK signalling pathway CEP 11004 in order to clarify these issues.Methods: Bronchial epithelial cells that had been pre-incubated with SB 203580, CEP 11004 or a combination of these were exposed to a hyperosmolar medium and then the p38 MAPK and JNK phosphorylation activity in these cells and IL-8 and RANTES concentrations in the culture supernatants were determined.Results: The results showed that: (i) hyperosmolarity induced the threonine and tyrosine phosphorylation of p38 MAPK and JNK; (ii) SB 203580, as the specific inhibitor of p38 MAPK activity, and CEP 11004 attenuated hyperosmolarity induced p38 MAPK and JNK activity, respectively; (iii) SB 203580 and CEP 11004, but not PD 98059, partially attenuated IL-8 and RANTES production; and (iv) a combination of SB 203580 and CEP 11004 attenuated IL-8 and RANTES production in an additive fashion.Conclusion: These results indicate that p38 MAPK and the JNK pathway regulate hyperosmolarity induced IL-8 and RANTES production by BEC.